Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice

Farhad Nikkhahi, Mohammad Mehdi Soltan Dallal, Mahmood Alimohammadi, Abbas Rahimi foroushani, Zahra Rajabi, Fatemeh Fardsanei, Seyed Mostafa Imeni, Parisa Torabi Bonab

Abstract


140

Aim: This work aims to isolate and perform comparative studies of a phages active against a Salmonella enteritidis strain from Iran. Also, suitable phage candidates for therapy of mice will be selected.

Background: Bacteriophage is of particular interest as a biocontrol agent in the prevention of food-borne illnesses. In recent years tend to use bacteriophages to control pathogenic bacteria has increased. A bacteriophage is considered to be a potent antibiotic alternative for treating bacterial infections.

Methods: the specific phages against Salmonella Enteritidis was isolated and candidates for therapy of mice will be selected. Mouses divided into the six specific groups. Groups of mice were as follows: A: Bacteri (control) B: Bacteri+ bacteriophage (Simultaneous), C: Bacteri + bacteriophage Four days later, D: Bacteriophage + bacteri four days later E: Bacteri+ Ciprofloxacin (Simultaneous) F: Bacteri+ ciprofloxacin+ bacteriophage (Simultaneous).

Results: In this study, a lytic bacteriophage is isolated and it shows that phage has a head size of 46 nm and without a tail, by using an electron microscope. Oral administration of a single dose of 2 × 109 PFU/mouse bacteriophage enable to protect mouse against salmonellosis and it causes treatment of salmonellosis in mice.

Conclusion: The use of this phage compared to ciprofloxacin shows that in addition of the treatment of mouse, it also prevents weight loss.


Keywords


Bacteriophage, Salmonella enteritidis, Isolation

Full Text:

PDF - View Count=45

References


Capparelli R, Nocerino N, Iannaccone M, Ercolini D, Parlato M, Chiara M, Iannelli D: Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis 2010; 201(1),52-61

Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, Barzilay EJ: Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother 2011; 55(3),1148-54

Ercis S, Erdem B, Hasçelik G, Gür D: Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey. Jpn J Infect Dis 2006; 59(2),117-9

Segovia C, Vasquez I, Maracaja-Coutinho V, Robeson J, Santander J:Complete Genome Sequence of Salmonella enterica Serovar Enteritidis Bacteriophage f18SE, Isolated in Chile. Genome Announc 2015; 3(5)

Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S:Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by acloneO25b:H4-ST131Escherichia coli strain producing CTXM-15,” Antimicrob Agents Chemother 2012; 56(7), 3568–3575

Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R, Merril CR:Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin resistant Enterococcus faecium,” Infection and Immunity 2002; 70(1),204–210

Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X: A method for generation phage cocktail with great therapeutic potential, PLoSONE 2012 ;7(3)

Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST: Phagetherapy in clinical practice :treatment of human infections, Current Pharmaceutical Biotechnology 2010; 11(1), 69–86

Brüssow H: What is needed for phage therapy to become a reality in Western medicine? Virology,2012 ;434(2), 138– 142

Chan BK , Abedon ST, Loc-Carrillo C: Phage cocktails and the future of phage therapy, Future Microbiology 2013; 8(6), 769–783

Cao F, Wang X, Wang L, Li Z, Che J, Wang L, Li X, Cao Z, Zhang J, Jin L, Xu Y: Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed Res Int. (2015 )

Dunkley, K.D.; Callaway, T.R.; Chalova, V.I.; McReynolds, J.L.; Hume, M.E.; Dunkley, C.S.; Kubena, L.F.; Nisbet, D.J.; Ricke, S.C: Foodborne Salmonella ecology in the avian gastrointestinal tract. Anaerobe 15, 26–35(2009)

Galarce, N.E.; Bravo, J.L.; Robeson, J.P.; Borie, C.F. Bacteriophage cocktail reduces Salmonella enterica serovar Enteritidis counts in raw and smoked salmon tissues. Rev. Argent. Microbiol 2014; 46, 333–337

Kutateladze, M.; Adamia, R. Phage therapy experience at the Eliava Institute. Med. Mal. Infect 2008; 38, 426–430

Harper DR , Enright MC. Bacteriophages for the treatment of Pseudomonas aeruginosa infections, J Appl Microbiol 2011

Morello E, Saussereau E, Maura D, Huerre M, Touqui L, Debarbieux L:Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: First steps towards treatment and prevention PLoS One 2011; 15(6)

Bordon J , Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, Peyrani P, Morlacchi LC, Blasi F, Ramirez JA:Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia, Int J Infect Dis 2013; 76-83

Kang HW , Kim JW, Jung TS, Woo GJ. wksl3, a New biocontrol agent for Salmonella enterica serovars enteritidis and typhimurium in foods: characterization, application, sequence analysis, and oral acute toxicity study. Appl Environ Microbiol 2013 79(6),1956-68

Gilles B, Armando N, Shafiqul A. S, Anne-C. Pittet , Firdausi Q , Shamima S, Alejandro C, Kaisar A. Talukder , Gloria R andHarald B . Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails. Microbial Biotechnology 2014; 7(2), 165–176

Firoozeh F, Zahraei-Salehi T, Shahcheraghi F, Karimi V, Aslani MM: Characterization of class I integrons among Salmonella enterica serovar Enteritidis isolated from humans and poultry. FEMS Immunol Med Microbiol 2012; 64(2):237-43




DOI: http://dx.doi.org/10.22037/ghfbb.v0i0.1003

Creative Commons License
GHFBB by Gastroenterology and Liver Diseases Research Institute is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

PISSN: 2008-2258

EISSN: 2008-4234


•  

Privacy Policy | For Author | Online Submission | About | Contact

Copyright © 2016 Shahid Beheshti University of Medical Sciences. All rights reserved.